| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |